Prostate cancer Board decisions

The Veteran's appeal for a higher rating for coronary artery disease status post myocardial infarction was withdrawn. The Veteran's residuals of prostate cancer from April 1, 2023 to June 27, 2023 were granted a 40 percent disability rating. The Veteran's PTSD remained denied and his TDIU claim was granted effective May 18, 2020. SMC at the housebound rate was granted from May 28, 2020 to June 30, 2020.

The Veteran's prostate cancer, non-Hodgkin lymphoma, and DM II are presumed to be related to his exposure to herbicide agents in service. Service connection is granted for these conditions as well as for ED secondary to DM II, kidney disability (diagnosed as diabetic CKD and kidney cancer), and CKD secondary to DM II. Hypertension is not considered presumptively related to herbicide exposure.

The Veteran's appeal for service connection of prostate cancer was dismissed due to his death during the pendency of the appeal.

The claims for prostate cancer, diabetes mellitus II, and high blood pressure remain denied as new and relevant evidence has not been received.,The claims for cervical spine condition, left ankle condition, right ankle condition, left hip condition, right hip condition, left shoulder condition, right shoulder condition, left knee condition, and right knee condition are all denied due to lack of service connection or no showing of a nexus between the conditions and service.

The Board has remanded the claims for service connection for prostate cancer, increased rating for left foot hallux valgus, and TDIU due to new and relevant evidence submitted by the appellant. The low back disability claim remains on appeal.

The Board has denied service connection for coronary artery disease, atrial fibrillation, mitral valve regurgitation, and prostate cancer as there is no probative evidence linking these conditions to the Veteran's active service or exposure to contaminated water at Camp Lejeune.

The Veteran's migraines are currently rated at 30 percent, effective October 17, 2019. The left-sided rib lesion and seborrheic keratosis have not been service-connected.,Service connection for prostate cancer is granted under the PACT Act.

The Board has granted service connection for prostate cancer, finding that the evidence is at least as likely as not that it was caused by exposure to ionizing radiation during service.

Entitlement to an earlier effective date of July 11, 2024 for the award of service connection for prostate cancer is granted.,Entitlement to an earlier effective date of July 11, 2024 for the award of service connection for bone metastases, to include as secondary to prostate cancer, is granted.,Entitlement to an earlier effective date of July 11, 2024 for the award of special monthly compensation (SMC) based on housebound criteria is granted.,Entitlement to an earlier effective date of February 27, 2023 for the award of a 20 percent disability rating for lumbar radiculopathy of the right lower extremity, to include diabetic peripheral neuropathy, peripheral polyneuropathy, and paresthesia of the feet, is granted.,Entitlement to an earlier effective date of February 27, 2023 for the award of a 20 percent disability rating for lumbar radiculopathy of the left lower extremity, to include diabetic peripheral neuropathy, peripheral polyneuropathy, and paresthesia of the feet, is granted.

The Board has remanded the cases of prostate cancer and bone cancer for further review due to inadequate medical opinions regarding service connection.

The Board denied the Veteran's claims for special monthly compensation on both the basis of housebound status and need for aid and attendance, finding that his service-connected disabilities did not meet the criteria for either benefit.

The Veteran's prostate cancer, erectile dysfunction, and voiding dysfunction are denied as service connection due to lack of evidence linking these conditions to his military service or exposure at Camp Lejeune.

The Board denied the appellant's request for attorney fees based on past-due benefits awarded in the May 2024 rating decision, as the claims were not related to service connection.

The appellant's service-connected prostate cancer has been granted eligibility for permanently and totally disabled status, with a 100 percent disability rating since March 2023.

The Veteran's prostate cancer was incurred in or caused by his active-duty service, and the Board has granted service connection for this condition.

The Board restored service connection for the Veteran's claimed conditions as they were previously granted on a presumptive basis due to herbicide exposure, finding that the original decision was not clearly and unmistakably erroneous.

The Board has found that the VA opinions of record are inadequate to fairly adjudicate the claims and requires new opinions on the etiology of the Veteran's claimed conditions.

The Veteran's prostate cancer is not service-connected as it was not incurred in or caused by his military service, including exposure to contaminated water at Camp Lejeune.

The Board has decided that the Veteran's claim of service connection for prostate cancer should be remanded due to insufficient evidence regarding his reported exposures during service.

The Board has granted service connection for prostate cancer due to asbestos exposure during service. The claim for aortic aneurysm is remanded as the VA examination was insufficient.